Adverse effects experienced by patients taking timolol.
Adverse effects involving one or more organ systems occurred in 38 of 165 patients with various types of glaucoma when timolol was added to their glaucoma therapy. It was necessary to discontinue timolol because of these side effects in 15 (9%) of the patients. Double-masked studies will be necessary to clarify the relationship of these adverse effects to the use of timolol.
D000368:Aged; D001249:Asthma / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000139:chemically induced; D002648:Child; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000009:adverse effects*; D012140:Respiratory Tract Diseases / Q000139:chemically induced; D013999:Timolol / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced
D011412:Propanolamines; D013999:Timolol